Healthcare · Stock picks newsletter
Biotech Distilled: review of price, cadence & strategy
Skeptical, filings-first research on public biotech and biopharma companies.
Biotech Distilled publishes forensic deep dives on single public biotech and biopharma companies: the science, clinical data, patents and competition, the balance sheet and dilution math, ending in a Buy / Watch List / Pass verdict. Between deep dives, daily updates track catalysts, financings and data readouts. The writer says they hold a PhD in medicinal chemistry. Prices are the publication's web subscription prices on Substack.
Want to see what you get before paying? Read recent issues in the official archive.
Facts checked on 2026-10-26 at the official page. Prices can change; confirm before you subscribe. We do not publish ratings or performance claims.
Similar newsletters
Motley Fool Epic
The Motley Fool's flagship bundle of monthly stock picks and portfolio guidance.
Motley Fool Stock Advisor
Two stock recommendations a month, plus Top 10 rankings, for long-term investors.
Kiplinger Investing Weekly
A free twice-a-week roundup of stocks, funds and industries to consider or avoid.